Chongqing Pharscin Pharmaceutical Management
Management criteria checks 4/4
Chongqing Pharscin Pharmaceutical's CEO is Xiaoying Liu, appointed in Aug 2015, has a tenure of 9.83 years. directly owns 8.6% of the company’s shares, worth CN¥597.65M. The average tenure of the management team and the board of directors is 9.8 years and 6 years respectively.
Key information
Xiaoying Liu
Chief executive officer
CN¥404.8k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 9.8yrs |
| CEO ownership | 8.6% |
| Management average tenure | 9.8yrs |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
Pinning Down Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) P/S Is Difficult Right Now
Jan 13
Why Chongqing Pharscin Pharmaceutical's (SZSE:002907) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 04Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) Popularity With Investors Is Under Threat From Overpricing
Oct 03Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) 30% Price Boost Is Out Of Tune With Revenues
Mar 06CEO
Xiaoying Liu (63 yo)
Ms. Xiaoying Liu serves as the Chief Executive Officer of Chongqing Pharscin Pharmaceutical Co., Ltd. since August 19, 2015. She was President at Chongqing Pharscin Pharmaceutical Co., Ltd.Ms. Liu served...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, GM & Director | 9.8yrs | CN¥404.80k | 8.6% CN¥ 597.6m | |
| Accounting Supervisor & CFO | 9.3yrs | CN¥255.20k | 0.0042% CN¥ 291.3k | |
| Head of Phramaceutical Sales | no data | CN¥428.50k | 8.76% CN¥ 609.4m | |
| Deputy GM | 9.8yrs | CN¥331.70k | no data | |
| COO & Deputy GM | no data | CN¥131.50k | no data | |
| Chief Technology Officer | 13.4yrs | no data | no data | |
| Securities Affairs Representative | no data | no data | no data |
Experienced Management: 002907's management team is seasoned and experienced (9.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, GM & Director | 9.8yrs | CN¥404.80k | 8.6% CN¥ 597.6m | |
| Head of Phramaceutical Sales | 9.8yrs | CN¥428.50k | 8.76% CN¥ 609.4m | |
| Deputy GM | 3.1yrs | CN¥331.70k | no data | |
| Chairman of the Board | 9.8yrs | CN¥432.30k | 17.34% CN¥ 1.2b | |
| Director | 9.2yrs | no data | no data | |
| Non-Independent Director | less than a year | no data | no data | |
| Director | 6.2yrs | CN¥173.00k | no data | |
| Chairman of the Supervisory Board | 5.8yrs | no data | no data | |
| Employee Representative Supervisor | 6.2yrs | no data | no data | |
| Independent Director | 3.8yrs | CN¥83.40k | no data | |
| Independent Director | 3.1yrs | CN¥83.40k | no data | |
| Independent Director | less than a year | no data | no data |
Experienced Board: 002907's board of directors are considered experienced (6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/30 08:41 |
| End of Day Share Price | 2025/06/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Chongqing Pharscin Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.